Diabetes Drugs
Product Name
Tagrisso is a prescription medication used to treat specific types of non-small cell lung cancer (NSCLC) that carry mutations in the EGFR gene.
Please note: a valid prescription is required for all prescription medication.
Tagrisso is a third-generation tyrosine kinase inhibitor designed to target epidermal growth factor receptor (EGFR) mutations, helping control the growth of cancer cells in NSCLC. This advanced therapy offers proven benefits, including longer progression-free survival and improved overall outcomes compared to earlier EGFR inhibitors.
Tagrisso is available in dose options designed to match your treatment plan and your doctor’s prescription:
Tagrisso 40 mg, 30 tablets.
Tagrisso 80 mg, 30 tablets.
No reviews yet.
No shipping information available.
No rewards information available.
No doctor visit information available.
Tresiba FlexTouch Pens are prescription insulin delivery devices that contain insulin degludec, an ultra-long-acting basal insulin designed to provide stable...
Claritin Allergy Decongestant is a brand-name nasal spray designed to relieve nasal or sinus congestion and sinus pressure caused by seasonal or perennial al...
Eltroxin is a medicine used to treat hypothyroidism (an underactive thyroid gland).
Diabetes Drugs
Product Name
Your cart is empty